Conditional Global-First Nod For SanBio's Cell Therapy for TBI

But Product Consistency Challenge Looms

 
• By Lisa Takagi
SanBio's Akuugo can be the global first pharmaceutical product approved for TBI treatment.
• Source: Shutterstock

More from Japan

More from Focus On Asia